BioMarin Pharmaceutical Inc. (BMRN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for BioMarin Pharmaceutical Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
BioMarin Pharmaceutical Inc. (BMRN) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $10.7B. It trades at $56.00, up 1.17% today, at 148.5 times earnings. Its overall quality score is 54 out of 100, ranked against the whole US market. 24 analysts' average target of $91.73 implies +63.8% from today's price. Kronos AI's 30-day forecast is −1.3% (2 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $91.73 |
| Low – high | $60.00 – $122.00 |
| Analysts | 24 |
| Upside to average | +63.8% |
Kronos AI 30-day forecast
| Expected close | $54.65 (−1.3%) |
| Likely range | −3.8% … +3.4% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 46 |
| Solvency | 37 |
| Growth | 80 |
| Overall | 54 |
| P/E | 148.5 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator